Here are five observations:
1. In North America, an increasing adult population and demand for minimally invasive surgeries will drive the SCS market.
2. Therapy costliness and hindering regulations will serve as obstacles to the market’s growth.
3. North America dominates the global market because of the prominent manufacturers in the area.
4. In the North American market, hospitals account for 75 percent of the SCS end-user market.
5. Key market players include Medtronic, Nevro, St. Jude Medical, Greatbatch and Stimwave.
More articles on devices:
4 key notes on Stryker mid-year
Understanding the Science Behind the Hype
Simplify Medical reports $21M financing round; funds to support Simplify Disc clinical trials: 6 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
